ABEO
Abeona Therapeutics
$6.13
+$0.08 (+1.32%)Jul 27, 2026
Key metrics
The numbers that frame ABEO today
- Market cap
- $349.38M
- P/E (TTM)
- 5.3
- EV / FCF
- -3.7
- Gross margin
- 70.9%
- EV / Sales
- 21.4
- ROIC
- 57.3%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $4.00
- 52wk High
- $7.54
Growth
Revenue and earnings trend for ABEO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ABEO
Is Abeona Therapeutics a good buy?
No. Abeona Therapeutics has poor quality and mixed momentum. The setup is weak overall. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Abeona Therapeutics is selling at a fair price.
What is the market capitalization of ABEO?
Abeona Therapeutics's market capitalization is $349.38M.
What is the P/E ratio for ABEO stock?
Abeona Therapeutics's current P/E ratio is 5.3.
What is the 52-week high for ABEO stock?
The 52-week high for Abeona Therapeutics is $7.54. The current close of $6.13 is 18.7% below that high.
What is the 52-week low for ABEO stock?
The 52-week low for Abeona Therapeutics is $4.00. The current close of $6.13 is 53.3% above that low.
Does ABEO stock pay dividends?
Abeona Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ABEO?
Abeona Therapeutics's Debt / Equity ratio is 0.16.